otofa drops ear
laboratoires bouchara-recordati - rifamycin (rifamycin sodium) - drops ear - 26mg (20000iu)/ml
rifacin tablet dr tablet
navana pharmaceuticals ltd. - rifamycin - dr tablet - 194 mg
rifocin 250mg/3ml solution for injection
sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - rifamycin - solution for injection - 250mg/3ml - antimycobacterials: antibiotics
zyvox granules for oral suspension 20 mgml
pfizer private limited - linezolid - granule, for suspension - 20 mg/ml - linezolid 20 mg/ml
zyvox tablet 600 mg
pfizer private limited - linezolid - tablet, film coated - 600 mg - linezolid 600 mg
rifampin- rifampin injection, powder, lyophilized, for solution
fresenius kabi usa, llc - rifampin (unii: vjt6j7r4tr) (rifampin - unii:vjt6j7r4tr) - rifampin 600 mg - in the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin and they should be repeated throughout therapy to monitor the response to treatment. since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. if test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified. rifampin is indicated in the treatment of all forms of tuberculosis. a three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of short-course therapy which is usually continued for 2 months. the advisory council for the elimination of tuberculosis, the american thoracic
diazemuls
accord healthcare limited - diazepam - emulsion for injection - 5 mg/ml - diazepam
kaletra 80mg20mg1ml oral solution
abbvie ltd - ritonavir; lopinavir - oral solution - 20mg/1ml ; 80mg/1ml
noxafil 300mg16.7ml concentrate for solution for infusion vials
merck sharp & dohme ltd - posaconazole - solution for infusion - 18mg/1ml